![]() |
|
|
The Department of Nutrition and Food Science and the Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48202
2To whom correspondence should be addressed. E-mail: ndhurand{at}sun.science.wayne.edu.
| INTRODUCTION |
|---|
|
|
|---|
The main question being, why were these pathogen-disease
interactions not discovered earlier? Have the pathogens recently
changed their pathophysiology? Or has this age-old phenomenon been
discerned lately? Both are potential possibilities. For instance, two
different viruses are known to "merge" into each other to form a
new strain of virus by reassortment, as in the case of James Town
Canyon virus and La Crosse virus (1)
, and to thereby
acquire new characteristics. Such adaptations and changes in pathogens
may reflect in symptom manifestations in a host, and newer disease
expressions may be detected. Similarly, mutations may enable viruses to
change host species and/or resulting pathology. A well-known
example of this phenomenon is the sudden outbreak of Canine Distemper
Virus (CDV)3<-foot;1781f3;10;ZPICKFOOT;Fn3>, a
member of the morbillivirus family, in the lions of Serengeti, Tanzania
(2)
, who were thought to have received the virus from
domestic dogs, the established host of CDV (3)
.
Historically, CDV is known to infect members of the canine but not the
cat family. The Serengeti epidemic was due to the mutation of CDV,
which probably enabled the virus to jump the host species as well as
the expression of the disease.
New relationships with pathogens emerge because of changes in pathogens as well as because of the discovery of new pathogens. Pathogens such as Scrapie agent and hepatitis C virus are relative newcomers in the area, and it is possible that much remains to be discovered in regard to their pathogenic potential. The roles of Scrapie agent in obesity and hepatitis C virus in type 2 diabetes are described in the symposium.
On the other hand, perhaps, the emerging link of pathogens with various
chronic diseases is not a recent development but a result of the modern
sophisticated investigational abilities. A case in point is the recent
research on Borna Disease Virus (BDV), the agent responsible for Borna
Disease (BD). For more than a century, BD was known to be an affliction
of horses and sheep, in which it caused nonpurulent encephalomyelitis.
Traditionally, BDV was not thought to infect humans, but this belief
has been overturned by several publications in the last decade, such as
the reverse transcriptasepolymerase chain reactionaided
demonstration of BDV RNA in the peripheral blood of humans
(4)
. It is not surprising that, when armed with new
technology, we find pathogens in new places and we discover new roles
for pathogens.
It is unknown if any of the above-stated theories are applicable to the chronic diseasespathogens links discussed in this symposium. By definition, chronic diseases have an insidious onset, which makes it difficult to recognize the link between a causative organism and the expression of the disease. To make matters worse, establishing a causal link is more difficult if the pathogen is of the "hit-and-run" type (i.e., the presence of the organism is undetectable by the time the disease is diagnosed). In addition, there remains the task of determining the relative contribution, if any, of an infectious agent to the etiology of the suspected chronic disease.
This symposium was planned to critically examine the claims concerning the role of various infectious agents in the chronic diseases presented. In an accompanying article, Dr. Lawrence Cheskin has nicely summarized the symposium. A relative lack of information about the "modus operandi" of various pathogens thwarts this nascent field. Clearly, more research is needed to firmly establish pathogens as one of the causes in human obesity, diabetes, autoimmune liver disorders and atherosclerosis. Nevertheless, the current data in the area are provocative. The concept of infectious agents as one of the causative factors may lead to appropriately directed management efforts for these diseases as well as to a search for additional pathogens that may be causally involved in various other chronic diseases.
| FOOTNOTES |
|---|
3 Abbreviations used: CDV, Canine Distemper Virus;
BDV, Borna Disease Virus; BD, Borna Disease. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Cheng L. L., Rodas J. D., Schultz K. T., Christensen B. M., Yuill T. M. & Israel B. A. (1999) Potential for evaluation of California serogroup bunyaviruses by genome reassortment in Aeded albopictus. Am. J. Trop. Med. Hyg. 60:430-438.[Abstract]
2. Roelke-Parker M. E., Munsonn L., Packer C., Kock R., Cleaveland S., Carpenter M., OBrien S. J., Pospischil A., Hofmann-Lehmann R. & Lutz H. (1996) A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 379:441-445.[Medline]
3. Cleaveland S., Appel M. G., Chalmers W. S., Chillingworth C., Kaare M. & Dye C. (2000) Serological and demographic evidence for domestic dogs as a source of canine distemper virus infection for Serengeti wildlife. Vet Microbiol 72:217-227.[Medline]
4. Chen C. H., Chiu Y. L., Shaw C. K., Tsai M.T., Hwang A. L. & Hsiao K. J. (1999) Detection of Borna disease virus RNA from peripheral blood cells in schizophrenic patients and mental health workers. Mol. Psychiatry 4:566-571.[Medline]
This article has been cited by other articles:
![]() |
J. Y. Lee, A. Plakidas, W. H. Lee, A. Heikkinen, P. Chanmugam, G. Bray, and D. H. Hwang Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids J. Lipid Res., March 1, 2003; 44(3): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||